Ranking Profile - iBio Inc
Introduction
iBio Inc (iBio) is a biotechnology company. It develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. Its pipeline products includes IBIO-100, IBIO-202 for Covid-19 and IBIO-400 for classical swine fever. The company's IBIO-100 is helpful for the treatment of idiopathic pulmonary fibrosis, fibrotic diseases and systemic sclerosis, among others. In addition, it is producing animal-free proteins using the FastPharming System. iBio offers CDMO services comprise of process development, cGMP manufacturing, aspetic fill, factory solutions and bioanalytic. It collaborates with medical universities for its research and development activities. iBio is headquartered in Bryan, Texas, the US.
Company info
Country (HQ): | United States |
Sector: | Pharmaceuticals and Healthcare |
Market Cap (US$ m): | 16 |
Revenue (US$ m): | 2 (2022) |
Innovation ranking
Innovation score
Closest peers in the Pharmaceuticals and Healthcare sector
Innovation Ranking
Johnson & Johnson
United States
Pharmaceuticals and Healthcare
F. Hoffmann-La Roche Ltd
Switzerland
Pharmaceuticals and Healthcare
iBio Inc
United States
Pharmaceuticals and Healthcare
EyeGate Pharmaceuticals Inc
United States
Pharmaceuticals and Healthcare
Shin Poong Pharm Co Ltd
South Korea
Pharmaceuticals and Healthcare
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release